Myriad Genetics, Inc. (MYGN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 200.4M | 209.8M | 205.7M | 213.1M | 195.9M | 210.6M | 213.3M | 211.5M | 202.2M | 196.6M | 191.9M | 183.5M |
| Revenue Growth % | 2.3% | -0.38% | -3.56% | 0.76% | -3.12% | 7.12% | 11.15% | 15.26% | 11.59% | 10.57% | 22.7% | 2.34% |
| Cost of Goods Sold | 62.8M | 63M | 61.9M | 61.3M | 61.7M | 59.7M | 63.5M | 64.4M | 64.6M | 61.6M | 57.6M | 57.8M |
| COGS % of Revenue | 31.34% | 30.03% | 30.09% | 28.77% | 31.5% | 28.35% | 29.77% | 30.45% | 31.95% | 31.33% | 30.02% | 31.5% |
| Gross Profit | 137.6M | 146.8M | 143.8M | 151.8M | 134.2M | 150.9M | 149.8M | 147.1M | 137.6M | 135M | 134.3M | 125.7M |
| Gross Margin % | 68.66% | 69.97% | 69.91% | 71.23% | 68.5% | 71.65% | 70.23% | 69.55% | 68.05% | 68.67% | 69.98% | 68.5% |
| Gross Profit Growth % | 2.53% | -2.72% | -4.01% | 3.2% | -2.47% | 11.78% | 11.54% | 17.02% | 12.79% | 8.96% | 26.7% | -3.01% |
| Operating Expenses | 162.9M | 152.5M | 167.1M | 481M | 163.2M | 189.9M | 169.8M | 183.6M | 165.5M | 166.4M | 194.4M | 239.4M |
| OpEx % of Revenue | 81.29% | 72.69% | 81.23% | 225.72% | 83.31% | 90.17% | 79.61% | 86.81% | 81.85% | 84.64% | 101.3% | 130.46% |
| Selling, General & Admin | 135.8M | 124.3M | 138.9M | 138.7M | 135.7M | 136M | 139.1M | 144.9M | 140.6M | 32.6M | 136.1M | 140.7M |
| SG&A % of Revenue | 67.76% | 59.25% | 67.53% | 65.09% | 69.27% | 64.58% | 65.21% | 68.51% | 69.54% | 16.58% | 70.92% | 76.68% |
| Research & Development | 27.1M | 25.5M | 28.2M | 25.6M | 27.5M | 32.2M | 28.5M | 27.1M | 24.9M | 21M | 24M | 21.2M |
| R&D % of Revenue | 13.52% | 12.15% | 13.71% | 12.01% | 14.04% | 15.29% | 13.36% | 12.81% | 12.31% | 10.68% | 12.51% | 11.55% |
| Other Operating Expenses | 0 | 1000K | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K |
| Operating Income | -25.3M | -5.7M | -23.3M | -329.2M | -29M | -39M | -20M | -36.5M | -27.9M | -31.4M | -60.1M | -113.7M |
| Operating Margin % | -12.62% | -2.72% | -11.33% | -154.48% | -14.8% | -18.52% | -9.38% | -17.26% | -13.8% | -15.97% | -31.32% | -61.96% |
| Operating Income Growth % | 12.76% | 85.38% | -16.5% | -801.92% | -3.94% | -24.2% | 66.72% | 67.9% | 46.55% | 31.74% | -33.56% | -538.76% |
| EBITDA | -25.3M | 6.9M | -10.7M | -315.1M | -14.6M | -24.2M | -4.4M | -21.4M | -12.2M | -16.3M | -46M | -100.4M |
| EBITDA Margin % | -12.62% | 3.29% | -5.2% | -147.86% | -7.45% | -11.49% | -2.06% | -10.12% | -6.03% | -8.29% | -23.97% | -54.71% |
| EBITDA Growth % | -73.29% | 128.51% | -143.18% | -1372.43% | -19.67% | -48.47% | 90.43% | 78.69% | 62.69% | 47.92% | -44.2% | -1948.98% |
| D&A (Non-Cash Add-back) | 0 | 12.6M | 12.6M | 14.1M | 14.4M | 14.8M | 15.6M | 15.1M | 15.7M | 15.1M | 14.1M | 13.3M |
| EBIT | 0 | -4.5M | -22.4M | -329.1M | -28.6M | -38.4M | -20.4M | -36.4M | -25.4M | -31.4M | -60.2M | -115.6M |
| Net Interest Income | 0 | -3.6M | -3.3M | -1.3M | -500K | -400K | -400K | -400K | 100K | -200K | -400K | 0 |
| Interest Income | 700K | 800K | 500K | 200K | 300K | 300K | 400K | 400K | 600K | 700K | 600K | 500K |
| Interest Expense | -4.1M | 4.4M | 3.8M | 1.5M | 800K | 700K | 800K | 800K | 500K | 900K | 1M | 500K |
| Other Income/Expense | -8.8M | -3.2M | -2.9M | -1.4M | -400K | -100K | -1.2M | -700K | 2M | -900K | -1.1M | -2.4M |
| Pretax Income | -34.1M | -8.9M | -26.2M | -330.6M | -29.4M | -39.1M | -21.2M | -37.2M | -25.9M | -32.3M | -61.2M | -116.1M |
| Pretax Margin % | -17.02% | -4.24% | -12.74% | -155.14% | -15.01% | -18.57% | -9.94% | -17.59% | -12.81% | -16.43% | -31.89% | -63.27% |
| Income Tax | 0 | -1M | 1.2M | -100K | -29.3M | 3.4M | 900K | -500K | 100K | -1.1M | 100K | 0 |
| Effective Tax Rate % | 0% | 11.24% | -4.58% | 0.03% | 99.66% | -8.7% | -4.25% | 1.34% | -0.39% | 3.41% | -0.16% | 0% |
| Net Income | -34.1M | -7.9M | -27.4M | -330.5M | -100K | -42.5M | -22.1M | -36.7M | -26M | -31.2M | -61.3M | -116.1M |
| Net Margin % | -17.02% | -3.77% | -13.32% | -155.09% | -0.05% | -20.18% | -10.36% | -17.35% | -12.86% | -15.87% | -31.94% | -63.27% |
| Net Income Growth % | -34000% | 81.41% | -23.98% | -800.54% | 99.62% | -36.22% | 63.95% | 68.39% | 52.47% | 26.24% | -74.64% | -723.4% |
| Net Income (Continuing) | -34.1M | -7.9M | -27.4M | -330.5M | -100K | -42.5M | -22.1M | -36.7M | -26M | -31.2M | -61.3M | - |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.36 | -0.08 | -0.29 | -3.57 | -0.00 | -0.47 | -0.24 | -0.41 | -0.29 | -0.36 | -0.75 | -1.42 |
| EPS Growth % | - | 81.98% | -20.83% | -770.73% | 99.62% | -30.56% | 68% | 71.13% | 56.72% | 30.77% | -74.42% | -688.89% |
| EPS (Basic) | -0.36 | -0.08 | -0.29 | -3.57 | -0.00 | -0.47 | -0.24 | -0.41 | -0.29 | -0.36 | -0.75 | -1.42 |
| Diluted Shares Outstanding | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.9M | 81.7M |
| Basic Shares Outstanding | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.73M | 81.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |